Justices Won't Hear Pharma Case Over FCA's Public Info Bar
The U.S. Supreme Court declined on Monday to hear a pharmaceutical company's challenge to the Third Circuit's revival of a False Claims Act whistleblower suit, despite the corporation's complaint about a...To view the full article, register now.
Already a subscriber? Click here to view full article